nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0629	0.0899	CbGbCtD
Betaxolol—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0591	0.0846	CbGbCtD
Betaxolol—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0591	0.0846	CbGbCtD
Betaxolol—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0535	0.0765	CbGbCtD
Betaxolol—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0518	0.0741	CbGbCtD
Betaxolol—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0487	0.0697	CbGbCtD
Betaxolol—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0487	0.0697	CbGbCtD
Betaxolol—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0448	0.0641	CbGbCtD
Betaxolol—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.044	0.063	CbGbCtD
Betaxolol—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.044	0.063	CbGbCtD
Betaxolol—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0405	0.058	CbGbCtD
Betaxolol—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.038	0.0544	CbGbCtD
Betaxolol—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0369	0.0528	CbGbCtD
Betaxolol—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0334	0.0478	CbGbCtD
Betaxolol—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0334	0.0478	CbGbCtD
Betaxolol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.000523	CcSEcCtD
Betaxolol—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000523	CcSEcCtD
Betaxolol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000157	0.000522	CcSEcCtD
Betaxolol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.000521	CcSEcCtD
Betaxolol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000521	CcSEcCtD
Betaxolol—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.00052	CcSEcCtD
Betaxolol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.00052	CcSEcCtD
Betaxolol—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000519	CcSEcCtD
Betaxolol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000518	CcSEcCtD
Betaxolol—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000517	CcSEcCtD
Betaxolol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000516	CcSEcCtD
Betaxolol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.000516	CcSEcCtD
Betaxolol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000155	0.000515	CcSEcCtD
Betaxolol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000155	0.000514	CcSEcCtD
Betaxolol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000155	0.000514	CcSEcCtD
Betaxolol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000514	CcSEcCtD
Betaxolol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000513	CcSEcCtD
Betaxolol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000513	CcSEcCtD
Betaxolol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000513	CcSEcCtD
Betaxolol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000513	CcSEcCtD
Betaxolol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000511	CcSEcCtD
Betaxolol—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000511	CcSEcCtD
Betaxolol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000511	CcSEcCtD
Betaxolol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000509	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000509	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000507	CcSEcCtD
Betaxolol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000152	0.000507	CcSEcCtD
Betaxolol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000507	CcSEcCtD
Betaxolol—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000506	CcSEcCtD
Betaxolol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000506	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000506	CcSEcCtD
Betaxolol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000506	CcSEcCtD
Betaxolol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000503	CcSEcCtD
Betaxolol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000503	CcSEcCtD
Betaxolol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000502	CcSEcCtD
Betaxolol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000502	CcSEcCtD
Betaxolol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000501	CcSEcCtD
Betaxolol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.0005	CcSEcCtD
Betaxolol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00015	0.000499	CcSEcCtD
Betaxolol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000499	CcSEcCtD
Betaxolol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000498	CcSEcCtD
Betaxolol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00015	0.000497	CcSEcCtD
Betaxolol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00015	0.000497	CcSEcCtD
Betaxolol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000497	CcSEcCtD
Betaxolol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000496	CcSEcCtD
Betaxolol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000496	CcSEcCtD
Betaxolol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000495	CcSEcCtD
Betaxolol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000495	CcSEcCtD
Betaxolol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000493	CcSEcCtD
Betaxolol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000493	CcSEcCtD
Betaxolol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000493	CcSEcCtD
Betaxolol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000492	CcSEcCtD
Betaxolol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000491	CcSEcCtD
Betaxolol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000147	0.00049	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00049	CcSEcCtD
Betaxolol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000489	CcSEcCtD
Betaxolol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000487	CcSEcCtD
Betaxolol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000486	CcSEcCtD
Betaxolol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000484	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000484	CcSEcCtD
Betaxolol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000483	CcSEcCtD
Betaxolol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000483	CcSEcCtD
Betaxolol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000482	CcSEcCtD
Betaxolol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000482	CcSEcCtD
Betaxolol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000482	CcSEcCtD
Betaxolol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000482	CcSEcCtD
Betaxolol—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000481	CcSEcCtD
Betaxolol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000481	CcSEcCtD
Betaxolol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000481	CcSEcCtD
Betaxolol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00048	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000479	CcSEcCtD
Betaxolol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.000479	CcSEcCtD
Betaxolol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000479	CcSEcCtD
Betaxolol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000477	CcSEcCtD
Betaxolol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000477	CcSEcCtD
Betaxolol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000477	CcSEcCtD
Betaxolol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000475	CcSEcCtD
Betaxolol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000475	CcSEcCtD
Betaxolol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000475	CcSEcCtD
Betaxolol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000475	CcSEcCtD
Betaxolol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000474	CcSEcCtD
Betaxolol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000474	CcSEcCtD
Betaxolol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000474	CcSEcCtD
Betaxolol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000473	CcSEcCtD
Betaxolol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000472	CcSEcCtD
Betaxolol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000471	CcSEcCtD
Betaxolol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000471	CcSEcCtD
Betaxolol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000471	CcSEcCtD
Betaxolol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00047	CcSEcCtD
Betaxolol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000469	CcSEcCtD
Betaxolol—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000468	CcSEcCtD
Betaxolol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000468	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000467	CcSEcCtD
Betaxolol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000467	CcSEcCtD
Betaxolol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000465	CcSEcCtD
Betaxolol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000465	CcSEcCtD
Betaxolol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000465	CcSEcCtD
Betaxolol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000464	CcSEcCtD
Betaxolol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.000464	CcSEcCtD
Betaxolol—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000463	CcSEcCtD
Betaxolol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000462	CcSEcCtD
Betaxolol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000462	CcSEcCtD
Betaxolol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00046	CcSEcCtD
Betaxolol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.00046	CcSEcCtD
Betaxolol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000459	CcSEcCtD
Betaxolol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000459	CcSEcCtD
Betaxolol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000459	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000459	CcSEcCtD
Betaxolol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000458	CcSEcCtD
Betaxolol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000458	CcSEcCtD
Betaxolol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000458	CcSEcCtD
Betaxolol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000458	CcSEcCtD
Betaxolol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000457	CcSEcCtD
Betaxolol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000457	CcSEcCtD
Betaxolol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000456	CcSEcCtD
Betaxolol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000455	CcSEcCtD
Betaxolol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000455	CcSEcCtD
Betaxolol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000454	CcSEcCtD
Betaxolol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000454	CcSEcCtD
Betaxolol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.000453	CcSEcCtD
Betaxolol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000452	CcSEcCtD
Betaxolol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000451	CcSEcCtD
Betaxolol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000451	CcSEcCtD
Betaxolol—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000451	CcSEcCtD
Betaxolol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000449	CcSEcCtD
Betaxolol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000448	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000448	CcSEcCtD
Betaxolol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000135	0.000447	CcSEcCtD
Betaxolol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000447	CcSEcCtD
Betaxolol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000444	CcSEcCtD
Betaxolol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000444	CcSEcCtD
Betaxolol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000442	CcSEcCtD
Betaxolol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000442	CcSEcCtD
Betaxolol—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000442	CcSEcCtD
Betaxolol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000441	CcSEcCtD
Betaxolol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000441	CcSEcCtD
Betaxolol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000439	CcSEcCtD
Betaxolol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000438	CcSEcCtD
Betaxolol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000438	CcSEcCtD
Betaxolol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000438	CcSEcCtD
Betaxolol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000436	CcSEcCtD
Betaxolol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000433	CcSEcCtD
Betaxolol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000433	CcSEcCtD
Betaxolol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000432	CcSEcCtD
Betaxolol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000432	CcSEcCtD
Betaxolol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00013	0.000432	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000431	CcSEcCtD
Betaxolol—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00043	CcSEcCtD
Betaxolol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000428	CcSEcCtD
Betaxolol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000427	CcSEcCtD
Betaxolol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000425	CcSEcCtD
Betaxolol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000425	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000424	CcSEcCtD
Betaxolol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000424	CcSEcCtD
Betaxolol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000422	CcSEcCtD
Betaxolol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000422	CcSEcCtD
Betaxolol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000422	CcSEcCtD
Betaxolol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000422	CcSEcCtD
Betaxolol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00042	CcSEcCtD
Betaxolol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00042	CcSEcCtD
Betaxolol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00042	CcSEcCtD
Betaxolol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000418	CcSEcCtD
Betaxolol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000416	CcSEcCtD
Betaxolol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000416	CcSEcCtD
Betaxolol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000411	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000411	CcSEcCtD
Betaxolol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000409	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000408	CcSEcCtD
Betaxolol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000408	CcSEcCtD
Betaxolol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000408	CcSEcCtD
Betaxolol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000405	CcSEcCtD
Betaxolol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000405	CcSEcCtD
Betaxolol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000404	CcSEcCtD
Betaxolol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000404	CcSEcCtD
Betaxolol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000402	CcSEcCtD
Betaxolol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000402	CcSEcCtD
Betaxolol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000402	CcSEcCtD
Betaxolol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000398	CcSEcCtD
Betaxolol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000398	CcSEcCtD
Betaxolol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000398	CcSEcCtD
Betaxolol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000397	CcSEcCtD
Betaxolol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000396	CcSEcCtD
Betaxolol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000393	CcSEcCtD
Betaxolol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000392	CcSEcCtD
Betaxolol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000391	CcSEcCtD
Betaxolol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00039	CcSEcCtD
Betaxolol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00039	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000389	CcSEcCtD
Betaxolol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000389	CcSEcCtD
Betaxolol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000389	CcSEcCtD
Betaxolol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000388	CcSEcCtD
Betaxolol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000386	CcSEcCtD
Betaxolol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000386	CcSEcCtD
Betaxolol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000381	CcSEcCtD
Betaxolol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.00038	CcSEcCtD
Betaxolol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000376	CcSEcCtD
Betaxolol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000376	CcSEcCtD
Betaxolol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000375	CcSEcCtD
Betaxolol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000374	CcSEcCtD
Betaxolol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000374	CcSEcCtD
Betaxolol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000372	CcSEcCtD
Betaxolol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000371	CcSEcCtD
Betaxolol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00037	CcSEcCtD
Betaxolol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000368	CcSEcCtD
Betaxolol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000367	CcSEcCtD
Betaxolol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000364	CcSEcCtD
Betaxolol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000362	CcSEcCtD
Betaxolol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000358	CcSEcCtD
Betaxolol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000357	CcSEcCtD
Betaxolol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000353	CcSEcCtD
Betaxolol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000353	CcSEcCtD
Betaxolol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000351	CcSEcCtD
Betaxolol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00035	CcSEcCtD
Betaxolol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00035	CcSEcCtD
Betaxolol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000349	CcSEcCtD
Betaxolol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000348	CcSEcCtD
Betaxolol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000348	CcSEcCtD
Betaxolol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000348	CcSEcCtD
Betaxolol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000339	CcSEcCtD
Betaxolol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000338	CcSEcCtD
Betaxolol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000336	CcSEcCtD
Betaxolol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000335	CcSEcCtD
Betaxolol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000335	CcSEcCtD
Betaxolol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000335	CcSEcCtD
Betaxolol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000333	CcSEcCtD
Betaxolol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000332	CcSEcCtD
Betaxolol—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.92e-05	0.00033	CcSEcCtD
Betaxolol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000325	CcSEcCtD
Betaxolol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.74e-05	0.000324	CcSEcCtD
Betaxolol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.74e-05	0.000324	CcSEcCtD
Betaxolol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.6e-05	0.000319	CcSEcCtD
Betaxolol—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000316	CcSEcCtD
Betaxolol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.41e-05	0.000313	CcSEcCtD
Betaxolol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.000312	CcSEcCtD
Betaxolol—Rash—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.00031	CcSEcCtD
Betaxolol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.31e-05	0.00031	CcSEcCtD
Betaxolol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.29e-05	0.000309	CcSEcCtD
Betaxolol—Headache—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000308	CcSEcCtD
Betaxolol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000301	CcSEcCtD
Betaxolol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.000298	CcSEcCtD
Betaxolol—Rash—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000298	CcSEcCtD
Betaxolol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.96e-05	0.000298	CcSEcCtD
Betaxolol—Headache—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000296	CcSEcCtD
Betaxolol—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.78e-05	0.000292	CcSEcCtD
Betaxolol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000287	CcSEcCtD
Betaxolol—Rash—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000284	CcSEcCtD
Betaxolol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000284	CcSEcCtD
Betaxolol—Headache—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000283	CcSEcCtD
Betaxolol—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.45e-05	0.000281	CcSEcCtD
Betaxolol—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.06e-05	0.000268	CcSEcCtD
